Board Meetings for AMRUTANJAN
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| AMRUTANJAN | Amrutanjan Health Care Limited | 12 Feb 2020 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2019 and to declare second interim dividend for FY 19-20 | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 07 Nov 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2019 and to declare first interim dividend for the financial year 2019-20 | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 13 Aug 2019 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 23 May 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 12 Feb 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2018 and dividend | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 01 Nov 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2018 and declare First Interim dividend for the Financial Year 2018-19 | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 09 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 24 May 2018 | Financial Results/Dividend | To consider and approve, inter alia, the 1) Audited Financial Results along with the Audit Report of the Statutory Auditor for the Quarter and year ended March 31, 2018. 2)Declaration of Final Dividend for the financial year 2017-18 if any. | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 13 Feb 2018 | Results/Dividend/Stock-split | to consider and approve, inter alia to 1) Sub-division of equity shares of face value of Rs. 2/-each. 2) Un-audited Financial Results along with the limited review report for the quarter and nine months ended December 31, 2017. 3) Declaration of Second Interim Dividend for the financial year 2017-18. | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 09 Nov 2017 | Results/Dividend | To consider and approve, inter-alia, the a) Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2017. b) Declaration of 1st interim dividend for the financial year 2017-18 . | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 14 Aug 2017 | Results/Others | To consider and approve, inter-alia, the a) Un-audited Financial Results along with the Limited Review Report for the quarter ended June 30, 2017. b) Fix record date for the payment of dividend subject to the approval of the shareholders. | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 16 May 2017 | Results/Dividend | To consider and approve, inter-alia, the following: 1. Audited Standalone and Consolidated Financial Results along with the Report of the Statutory Auditor for the Quarter and Year ended March 31, 2017. 2. Declaration of Final Dividend for the financial year 2016-17; if any . | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 09 Feb 2017 | Results/Dividend | To consider and approve, inter-alia, the following: 1. Un-audited Standalone Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2016. 2. Declaration of 2nd interim dividend for the financial year 2016-17. | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 10 Nov 2016 | Results | To consider and approve , inter alia :Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter/half yearly ending September 30, 2016. | |
| AMRUTANJAN | Amrutanjan Health Care Limited | 10 Nov 2016 | Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held November 10, 2016, To consider and approve , inter alia :Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter/half yearly ending September 30, 2016.The Company has now informed the Exchange will also consider Declaration of Interim Dividends on quarterly basis & approval of 1st Interim Dividend for the year 2016-17(Purpose Revised). |